Clinical Trial Update: Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating allogeneic mesenchymal stem cell–derived exosome for acute ischemic stroke in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrovascular Disorders
• Stroke

Drugs mentioned

• Allogeneic mesenchymal stem cell–derived exosome

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Cerebrovascular Disorders | Phase 1, Phase 2 | Status: UNKNOWN